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Background: Lactic acid bacteria (LAB) are part of the gut microbiota and produce ribosomally synthesized antimicrobial
peptides or bacteriocins with interest as natural food preservatives and therapeutic agents. Bacteriocin-producing LAB are
also attractive as probiotics. Griffon vultures (Gyps fulvus subspecies fulvus) are scavenger birds that feed almost exclusively
on carrion without suffering apparent ill effects. Therefore, griffon vultures might be considered a reservoir of bacteriocin-
producing lactic acid bacteria (LAB) with potential biotechnological applications.
Results: Griffon vulture feces were screened for LAB with antimicrobial activity, genes encoding bacteriocins, potential
virulence determinants, susceptibility to antibiotics, genotyping and characterization of bacteriocins. In this study, from
924 LAB evaluated 332 isolates (36 %) showed direct antimicrobial activity against Gram-positive bacteria only. The
molecular identification of the most antagonistic 95 isolates showed that enterococci was the largest LAB group with
antimicrobial activity (91 %) and E. faecium (40 %) the most identified antagonistic species. The evaluation of the presence
of bacteriocin structural genes in 28 LAB isolates with the highest bacteriocinogenic activity in their supernatants
determined that most enterococcal isolates (75 %) encoded multiple bacteriocins, being enterocin A (EntA) the largest
identified (46 %) bacteriocin. Most enterococci (88 %) were resistant to multiple antibiotics. ERIC-PCR and
MLST techniques permitted genotyping and recognition of the potential safety of the bacteriocinogenic enterococci.
A multiple-step chromatographic procedure, determination of the N-terminal amino acid sequence of purified
bacteriocins by Edman degradation and a MALDI TOF/TOF tandem MS procedure permitted characterization
of bacteriocins present in supernatants of producer cells.
Conclusions: Enterococci was the largest LAB group with bacteriocinogenic activity isolated from griffon
vulture feces. Among the isolates, E. faecium M3K31 has been identified as producer of enterocin HF (EntHF),
a bacteriocin with remarkable antimicrobial activity against most evaluated Listeria spp. and of elevated
interest as a natural food preservative. E. faecium M3K31 would be also considered a safe probiotic strain for
use in animal nutrition.
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Lactic acid bacteria (LAB) are part of the gut microbiota
of mammals and birds with an important role in
environmental, food and clinical microbiology. Many
LAB produce ribosomally synthesized antimicrobial
peptides or bacteriocins which attract considerable
interest as natural and nontoxic food preservatives [1],
and as therapeutic agents for human and veterinary
applications and in the animal production field [2, 3].
Bacteriocin-producing LAB are also attractive vectors
for delivery of therapeutic peptides and proteins and as
probiotics [4–6].
Most bacteriocins produced by LAB are synthesized as
biologically inactive precursors or prepeptides containing
an N-terminal extension that is cleaved off during export to
generate their biologically active or mature form. They are
generally divided into two main classes. Class I consists of
the lanthionine-containing post-translationally modified
bacteriocins or lantibiotics, while class II consists of the
bacteriocins containing non-modified amino acids. The
class II bacteriocins may be further subdivided into the
pediocin-like (class IIa) bacteriocins, the two-peptide
(class IIb) bacteriocins, the cyclic (class IIc) bacteriocins,
and the non-pediocin-like one peptide linear (class IId)
bacteriocins [7, 8]. However, additional subgroups have
been suggested for leaderless peptides, circular bacterio-
cins, linear peptides derived from large proteins, and the
glycosylated bacteriocins [9].
Environmental sources as well as wild and game
animals are a powerful source of bacteriocin-producing
LAB [10–12]. Griffon vultures (Gyps fulvus subspecies
fulvus) belong to the Old World vultures group, a diverse
mix of colonial cliff-nesting scavenger birds that play an
essential ecological role as garbage collectors and recyclers.
Their feeding habits are based almost exclusively on
carrion, preferentially of mammals. Consequently, their gut
microbiota may derive from ecological and evolutionary
strategies for carrion exploitation [13]. Symbiotic relation-
ships among animal hosts and bacteria that confer protec-
tion against pathogens are widespread in nature and are
considered a driving force in evolution [14]. Therefore,
griffon vultures might be considered as potential reservoirs
of bacteriocin-producing LAB, with potential biotechno-
logical applications. This work constitutes a first approach
on the evaluation of the antimicrobial activity and safety
aspects of bacteriocinogenic LAB isolated from griffon
vulture feces.
Methods
Microbiological analysis, indicator strains and
bacteriocinogenic assays
Fresh fecal samples from griffon vultures (Gyps fulvus
subspecies fulvus) were collected from the Parque
Natural del Alto Tajo (Molina de Aragón, Guadalajara,Spain), and placed into sterile disposable plastic tubes at
4 °C. Samples were 10-fold diluted in sterile peptone
water (Oxoid Ltd., Basingstoke, UK) and homogenized
in a stomacher. Aliquots from decimal dilutions of the
homogenates were spread on duplicate plates of (i)
Triptycase Soya Agar (TSA; Oxoid) at 37 °C, 48 h for
aerobic mesophilic counts, (ii) on de Man, Rogosa, and
Sharpe (MRS) plates (Oxoid) at 37 °C, 48 h for growth
of LAB, and (iii) on Slanetz and Bartley (SB) plates
(Oxoid) and Kanamycin Aesculin Azide (KAA) plates
with the kanamycin selective supplement (Oxoid) at 37 °C,
48 h for growth of the enterococci. The direct antimicrobial
activity of randomly selected isolates was screened by the
stab-on-agar test (SOAT) [15] against three Gram-positive
and four Gram-negative indicator bacteria. Next, cell-free
supernatants of isolates producing halos of inhibtion lar-
ger than 7 mm or antimicrobial activity against, at least,
three Gram positive indicator strains were evaluated for
their antimicrobial activity by an agar diffusion test
(ADT), against a larger number of Gram-positive indica-
tors. Finally, the most active isolates were also evaluated
for the antimicrobial activity of their supernatants by a mi-
crotiter plate assay (MPA) [15] against Listeria spp.
strains. In the MPA test, one bacteriocin unit (BU) is de-
fined as the reciprocal of the highest dilution of the bac-
teriocin causing 50 % growth inhibition (50 % of the
turbidity of the control culture without bacteriocin). Su-
pernatants were subjected to proteolytic treatment with
proteinase K (Sigma-Aldrich GmbH, Madrid, Spain), at
10 mg/ml for 37 °C during 2 h, to ascertain the protein
nature of their antagonistic activity. After proteinase
inactivation by heat treatment (100 °C, 10 min), sam-
ples were assayed for residual antimicrobial activity by
ADT, as described above, using Pediococcus damnosus
CECT4797 as the indicator microorganism. Strains
with antimicrobial activity in their supernatants and
susceptible to proteinase treatment were considered
Bac+ and selected for further characterization. Indica-
tor strains and specific bacterial growth conditions
used in this study are shown in Table 1.
PCR analysis, DNA sequencing and other DNA
manipulations
PCR amplifications were performed from total bacterial
DNA obtained using the InstaGene matrix (Bio-Rad labora-
tories Inc., Hercules, CA, USA) in 25 or 50 μl reaction mix-
tures containing MyTaq mix buffer (Bioline Reagents Ltd.,
London, UK), 0.7 μM of each primer and 1 μl of purified
DNA. Oligonucleotide primers were obtained from Sigma
Genosys Ltd. (Cambridge, UK). Samples were subjected to
PCR amplification in an Eppendorf Mastercycler thermal
cycler (Eppendorf, Hamburg, Germany). When needed, the
resulting PCR fragments were purified using the NucleoS-
pin Extract II kit (Macherey-Nagel, Düren, Germany) and
Table 1 Indicator species and specific bacterial growth







BFE 1071 [54] MRS 37
DAC9 DNBTA MRS 37
DBH9 DNBTA MRS 37
DBH18 DNBTA MRS 37
INIA 4 INIA MRS 37
JH2-2 HRC MRS 37
P4 IFR MRS 37
V583 LMG MRS 37
Enterococcus faecium
L50 DNBTA MRS 37
M3K31 This work MRS 37
P13 DNBTA MRS 37
T136 DNBTA MRS 37
Enterococcus hirae DCH5 DNBTA MRS 37
Lactobacillus sakei 2714 NCDO MRS 37
Lactococcus lactis BB24 DNBTA MRS 37
Listeria grayii 931 CECT BHI 37
Listeria innocua 910 CECT BHI 37
Listeria ivanovii 913 CECT BHI 37
Listeria seeligeri 917 CECT BHI 37
Listeria welshimeri 919 CECT BHI 37
Listeria monocytogenes 911 CECT BHI 37
Listeria monocytogenes 935 CECT BHI 37
Listeria monocytogenes 936 CECT BHI 37
Listeria monocytogenes 939 CECT BHI 37
Listeria monocytogenes 4031 CECT BHI 37
Listeria monocytogenes 4032 CECT BHI 37
Pediococcus damnosus 4797 CECT MRS 32
Pediococcus pentosaceus FBB61 ATCC MRS 32
Gram-negative
Aeromonas salmonicida 3776 LMG TSB 28
Campylobacter jejuni 33560 ATCC BHI + 1 % horse serum 37
Campylobacter jejuni 11168 NCTC BHI + 1 % horse serum 37
Yersinia ruckeri 3279 LMG TSB 28
aAbbreviations as: ATCC American Type Culture Collection, VA, USA, CECT
Colección Española de Cultivos Tipo, Valencia, Spain, DNBTA Departamento de
Nutrición, Bromatología y Tecnología de los Alimentos, Facultad de Veterinaria,
Universidad Complutense de Madrid, Madrid, Spain, HRC Servicio de
Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de
Investigaciones Sanitarias (IRYCIS), Madrid, Spain, IFR Institute of Food
Research, Norwich, UK, INIA Instituto Nacional de Investigación y Tecnologıía
Agraria y Alimentaria, Madrid, Spain, LMG Laboratorium voor Microbiologie,
University of Ghent, Ghent, Belgium, NCDO, National Collection of Dairy
Organisms, Aberdeen, Scotland, UK; NCTC National Collection of Type Type
Cultures, Salisbury, UK
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de Madrid, Facultad de Ciencias Biológicas, Universidad
Complutense de Madrid, Spain).
Genus and species identification, and detection of
bacteriocin structural genes and potential virulence
factors
From the 332 LAB isolates showing direct antimicrobial
activity, 95 of them were taxonomically identified by PCR
amplification and sequencing of genes encoding 16S rRNA
(16S rDNA) with primers plb16/mlb16 [16], and the gene
encoding superoxide dismutase (sodA) with primers d1/d2
[17]. Genus and species identification was performed by
nucleotide BLASTanalysis using the NCBI platform.
The presence of bacteriocin structural genes of previ-
ously described bacteriocins, was evaluated in 28 LAB
isolates with the highest antimicrobial activity in their
supernatants. A total of 21 bacteriocin structural genes
were analysed including (i) the pediocin-like class IIa
bacteriocins avicin A (AviA), bacteriocin 31 (Bac31),
bacteriocin MC4-1 (BacMC4-1), enterocin A (EntA),
enterocin SE-K4 (EntSE-K4), enterocin P (EntP), hiracin
JM79 (HirJM79), mundticin L (MunL) and pediocin
PA-1 (PedA-1); (ii) the (ii) two-peptide class IIb bacte-
riocins enterocin 1071A-1071B (Ent1071A-Ent1071B)
and enterocin XA-XB (EntXA-EntXB); (iii) the circular
class IIc bacteriocin enterocin AS-48 (EntAS-48); (iv)
the class IId non-pediocin-like one peptide linear bacte-
riocins including the leaderless bacteriocins enterocin
L50 (EntL50A-EntL50B), enterocin JS (EntJSA-EntJSB)
and enterocin Q (EntQ), and other small heat-stable lin-
ear bacteriocins such as enterocin B (EntB), enterocin 96
(Ent96), enterocin IT (EntIT), enterocin V583 (EntV583)
and brevicin 925A (BreB); as well as the large bacterioly-
sin enterolysin A (EnlA). The specific oligonucleotide
primers, PCR conditions, positive control strains and
references concerning each of the bacteriocin structural
genes, are shown in Additional file 1: Table S1.
The presence of genes coding potential virulence factors
was evaluated in the nine most active bacteriocinogenic E.
faecalis isolates, by using primer pairs and PCR conditions
designed for detection of genes cylLL–cylLS (cytolysin pre-
cursor), cylM (postranslational modification of cytolysin),
cylB (transport of cytolysin), cylA (activation of cytolysin),
ace (adhesin to collagen), agg (aggregation substance), esp
(enterococcal surface protein), efaAfm and efaAfs (cell wall
adhesins of E. faecium and E. faecalis, respectively) and
gelE-sprE and sprE (gelatinase and serine protease E), as
previously described [10, 18].
Safety assessment of E. faecium M3K31
The safety assessment of the E. faecium M3K31 isolate
was determined according to guidelines established by
the European Food Safety Authority (EFSA) [19],
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determination of esp, a putative glycosyl hydrolase (hlyEfm)
and identification of the insertion sequence IS16 [20].
Production of gelatinase, caseinolytic and hemolytic
activity, and antibiotic susceptibility testing
For production of gelatinase, single colonies of the most
active nine bacteriocinogenic E. faecalis isolates, previ-
ously grown on MRS agar (Oxoid), were streaked onto
Todd-Hewitt agar (Oxoid) containing 30 g of gelatin
(Oxoid) per liter, grown overnight at 37 °C, and placed at
4 °C for 5 h before examination of zones of turbidity
around the colonies. The caseinolytic activity of the
isolates was evaluated by streaking the colonies onto TSA
agar (Oxoid) containing 1.5 % bovine skim milk powder
(Oxoid) and overnight growth at 37 °C. A clear zone of
hydrolysis within 24 h of growth was considered positive.
For investigation of their haemolytic activity, the strains
streaked on Columbia agar supplemented with 5 % (v/v)
horse blood (COH, BioMérieux, Madrid, Spain) were
grown at 37 °C for 1 to 2 days. Haemolysis was evidenced
by the formation of clear zones surrounding the colonies
on blood agar plates. The antibiotic susceptibility of the
27 selected enterococci with the highest antimicrobial
activity in their supernatants was determined by overlay-
ing antibiotic-containing disks (Oxoid) on the Diagnostic
Sensitivity Test Agar (Oxoid), following the Clinical and
Laboratory Standards Institute (CLSI) guidelines [21]. The
antibiotics tested were ampicillin (10 μg), chloramphenicol
(30 μg), ciprofloxacin (5 μg), erythromycin (15 μg), genta-
micin (120 μg), nitrofurantoin (300 μg), norfloxacin (10 μg),
penicillin G (10 IU), rifampicin (5 μg), teicoplanin (30 μg),
tetracycline (30 μg), and vancomycin (30 μg). Inhibition
zone diameters were measured after overnight incubation
of the plates at 37 °C. Resistance phenotypes were recorded
as recommended by the CLSI [21]. E. faecalis ATCC29212
and Staphylococcus aureus ATCC25923, were used as
control strains.
Enterobacterial repetitive intergenic consensus sequences
(ERIC-PCR) and multilocus sequence typing (MLST)
analysis
The clonal relationship among the 9 E. faecalis and 14
E. faecium isolates from griffon vultures feces with the
highest antimicrobial activity in their supernatants and
from other enterococci from food, environmental and
clinical origin was evaluated by ERIC-PCR, as previously
described [20]. The resulting patterns were interpreted
after constructing dendrograms using the unweighted-
pair group method with arithmetic mean (UPGM) and
the similarity on the Dice’s coefficient, analyzed with the
Phoretix v5.0 software (Nonlinear Dynamics Ltd., UK).
For MLST analysis, purified genomic DNA from selected
enterococcal isolates was used for PCR-amplification ofinternal fragments of seven housekeeping genes, as previ-
ously described [22]. The resulting PCR products were
purified with an ExoSAP-IT PCR clean up reagent (USB
Europe GmbH, Staufen, Germany) and sequenced in a
ABI Prism 377 automated sequencer (Applied Biosystems,
Foster City, CA, USA) at the Servicio de Microbiología,
Hospital Universitario Ramón y Cajal, and Instituto
Ramón y Cajal de Investigaciones Sanitarias (IRYCIS),
Madrid (Spain). Clusters of related sequence types (STs)
were grouped into clonal complexes (CCs) by using
eBURST (http://www.mlst.net).
Purification of bacteriocins
The peptides responsible of the antimicrobial activity of E.
faecium M1M10, E. faecium M3K31 and E. faecium T136
(producer of EntA) were purified to homogeneity by using
a multichromatographic procedure, as previously described
[23, 24]. Briefly, 1-L cultures of supernatants from the early
stationary phase were subjected to precipitation with
ammonium sulphate (50 %, w/v), desalted by gel filtration
(PD columns) and further subjected to cation-exchange (SP
Sepharose Fast Flow) and hydrophobic-interaction (Octyl-
Sepharose CL-4B) chromatographies, followed by reverse
phase chromatography (PepRPC HR 5/5) in a fast-protein
liquid chromatography system (ÄKTA, RP-FPLC). The
most active fractions from the last chromatographic step
were combined and rechromatographied on the reverse-
phase column to obtain the purified bacteriocin. All the
chromatographic columns and equipment were from GE
Healthcare (Madrid, Spain).
Mass spectrometry analysis and amino acid sequencing
Purified peptide fractions from the last RP-FPLC step were
subjected to matrix-assisted laser desorption–ionization
time-of-flight (MALDI-TOF) mass spectrometry (MS) at
the Unidad de Proteómica, Universidad Complutense de
Madrid (Madrid, Spain). MALDI-TOF MS analyses were
performed in a 4800 Proteomics Analyzer MALDI-TOF/
TOF mass spectrometer (Applied Biosystems, Framingham,
MA, USA), operated in 1 KV reflector mode. All mass
spectra were calibrated externally using a standard peptide
mixture (AB Sciex, Foster City, CA, USA).
MALDI TOF/TOF tandem mass spectrometry (MS)
was used to determine the partial amino acid sequence of
the purified peptide produced by E. faecium M3K31.
Acquisition of the MS data was performed on an Ultraflex
MALDI-TOF/TOF (Bruker Daltonics Inc. Billerica, MA,
USA) instrument operated in reflection mode with
delayed extraction, at the Proteomics Core Facility of the
Norwegian University of Life Sciences, Ås (Norway). MS/
MS spectra of selected peptides were recorded using the
LIFT ion optics of the mass spectrometer. Recorded spec-
tra were processed in flexAnalysis software (v3.3, Bruker
Daltonics) and mass lists submitted to database searches
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formed using an in-house Mascot server (v.2.1). Manual
annotation of MS/MS spectra (de novo sequencing) was
performed in flexAnalysis. The sequences generated were
searched against NCBI/taxonomy Firmicutes using protein
BLAST.
For N-terminal amino acid sequencing, the purified
peptide from E. faecium M1M10 was subjected to auto-
matic Edman degradation and sequence on polyvinylidene
difluoride membranes (PVDF) in a Procise 494 HT
Sequencing System (Applied Biosystems Inc., Foster City,
CA, USA) at the Centro de Investigaciones Biológicas
(CIB, Madrid, Spain).
Results
Identification of isolates with antimicrobial activity
In this study, 406 randomly selected isolates from griffon
vultures feces grown on MRS plates, 418 isolates grown in
SB plates and 100 isolates grown on KAA plates, were
evaluated for their direct antimicrobial activity (SOAT)
against 3 Gram-positive indicators (Pediococcus damnosus
CECT4797, Lactococcus lactis BB24 and Listeria innocua
CECT910) and 4 Gram-negative bacteria (Yersinia ruckeri
LMG3279, Aeromonas salmonicida LMG3776, Campylo-
bacter jejuni ATCC33560 and Campylobacter jejuni
NCTC11168). From the 924 LAB evaluated, 332 isolates
(36 %) showed direct antimicrobial activity against, at least,
one of the Gram-positive bacterial indicators tested.
However, no evidence for direct antimicrobial activity was
shown against any of the four Gram-negative bacteria
tested, including the two C. jejuni strains. From this initial
screening, 95 LAB isolates with the largest halos of
inhibition were identified by PCR amplification andTable 2 Antimicrobial activitya of supernatants from selected E. faec
Isolate Indicator microorganismsb
E. faecalis
BFE 1071 DAC9 DBH9 DBH18 INIA4 JH2-2 P4 V
E. faecalis
AS10 - - - - - - - 9
M1M32 - - - - - - - 7
M1S19 - - - - - - - -
M1S20 - - - - - - - -
M2M6 9.2 14.1 11.5 - - - 9.6 1
M2M39 - - - - - - - -
M3M42 9.4 13.6 10.0 - - - 8.6 8
M3S1 - - - - - - - -
PM2-13 - - - - - - - 8
aAntimicrobial activity determined by ADT. Results as the diameter of the inhibition
data are means from two independent determinations in triplicate
bSource of indicator microorganisms indicated in Table 1sequencing of genes encoding 16S rDNA and sodA.
From these results 38 E. faecium (40 %), 30 E. faecalis
(31 %) 1 E. hirae (1 %), 1 E. mundtii (1 %), 5 Lactobacillus
brevis (5 %) and 1 Lactobacillus plantarum (1 %) strains
were identified. The remaining 19 isolates were identified
as Enterococcus spp. (20 %).
From the above cited 95 LAB isolates, a set of 28 isolates
comprising 9 E. faecalis, 16 E. faecium, 1 E. hirae, 1 E.
mundtii and 1 Lb. brevis were tested for antimicrobial activ-
ity in their supernatants by an agar diffusion test (ADT).
Among the E. faecalis isolates, E. faecalis M2M6 and E.
faecalis M3M42 were active against a number of Gram-
positive bacteria, but none of the isolates were active
against any of the Gram-negative indicators tested (Table 2).
When supernatants from E. faecium, E. hirae, E. mundtii
and Lb. brevis were tested for their antimicrobial activity
most E. faecium and the Lb. brevis isolate were active
against most Gram-positive indicators, with no antagonistic
activity observed for E. hirae M4S3. It is noteworthy to ob-
serve the high antimicrobial activity of E. faecium M3K31
against most of the bacterial Gram-positive indicators
tested. However, none of the enterococcal and the Lb.
brevis supernatants evaluated were active against C. jejuni
ATCC33560 (Table 3). Supernatants of the most antagonis-
tic LAB isolates (3 E. faecalis, 5 E. faecium, 1 E. mundtii,
and 1 Lb. brevis) were also evaluated against 11 Listeria
spp. by a microtiter plate assay (MPA). The supernatant of
E. faecium M3K31 was remarkably active against most of
the Listeria spp. evaluated (Table 4).
Evaluation of bacteriocin structural genes
Purified genomic DNA of the 28 selected LAB isolates

















.7 - - 7.2 - - - -
.4 - - 8.9 - - - -
- - 7.2 - - - -
- - 6.9 - - - -
1.1 12.0 - 16.8 - - - -
- - 8.2 - - - -
.3 12.6 - 10.3 - - - -
- - 6.7 - - - -
.5 - - 12.2 - - - -
halos in millimeters (mm). (−) Antimicrobial activity not detected. Most of the
Table 3 Antimicrobial activitya of supernatants from isolated E. faecium and other lactic acid bacteria (LAB)
Isolate Indicator microorganismsb
























DBH18 INIA4 JH2-2 V583 L50 M3K31 P13 T136
E. faecium
AS 41 11.5 7.6 11.7 12.8 15.2 12.7 13.4 - 13.6 - 17.9 12.1 13.4 20.4 - -
BS15 12.2 7.3 11.3 14.6 14.2 14.4 14.0 - 14.0 - 18.9 12.7 13.5 21.3 9.3 -
CS14 11.5 7.1 12.4 12.6 16.9 14.6 15.0 - 14.2 - 18.8 12.1 12.4 22.9 8.6 -
CS46 11.7 8.6 13.5 13.6 16.8 16.9 14.4 - 14.5 - 19.2 11.6 12.5 23.0 8.7 -
M1M10 10.0 - 11.3 13.0 15.1 13.0 14.8 - 14.3 - 15.2 12.4 12.3 21.0 - -
M1M26 9.4 - 11.8 13.3 15.5 12.6 14.1 - 14.6 - 15.2 11.8 11.6 20.9 - -
M2M33 - - - - - - - - - - 8.2 - - 12.2 - -
M2S31 9.4 - 11.1 11.5 14.2 13.8 14.4 - - - 14.5 11.3 12.4 16.8 - -
M3M31 11.0 7.0 11.8 13.9 16.4 14.6 14.9 - 14.1 - 15.8 12.3 13.2 20.9 9.7 -
M3M32 11.6 8.8 12.8 14.9 16.1 17.9 16.0 - 15.1 - 8.4 11.9 13.0 22.9 10.3 -
M3K31 16.3 15.5 14.3 16.4 16.9 - 18.7 17.8 16.8 18.2 18.0 15.3 17.0 26.4 19.2 -
M4M2 - - - - - - - - - - - - - 10.1 - -
PM1-27 11.2 - 10.7 14.0 13.9 12.7 15.8 - - - 19.0 11.1 13.6 17.2 - -
PM1-32 13.0 7.5 11.7 15.5 15.0 12.9 15.5 - - - 18.3 11.7 13.9 17.3 10.3 -
PM1-36 12.2 - 11.8 14.5 13.9 12.1 14.5 - - - 18.9 12.5 13.8 17.6 9.1 -
PM1-47 13.1 7.8 12.4 14.0 15.6 13.5 15.2 - - - 18.5 11.6 12.9 19.5 9.6 -
E. hirae
M4S3 - - - - - - - - - - - - - - - -
E. mundtii
M2M33 - - - - - - - - - - 8.2 - - 12.2 - -
L. brevis
PM1-26 11.1 - 10.0 14.6 15.1 12.5 14.0 - - - 17.0 11.1 12.6 16.0 - -
aAntimicrobial activity determined by ADT. Results as the diameter of the inhibition halos in millimeters (mm). (−) Antimicrobial activity not detected. Most of the
data are means from two independent determinations in triplicate
bSource of indicator microorganisms indicated in Table 1
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described bacteriocins. All isolates encoded, at least, one
described bacteriocin gene except E. hirae M4S3. From
the E. faecalis isolates evaluated all of them encoded
entV583, 6 isolates enlA, 5 isolates ent1071A-ent1071B,
2 isolates ent96 and 2 more isolates encoded entJSA-
entJSB. Five bacteriocin-producing genes (for ent96,
ent1071A-ent1071B, entJSA-entJSB, entV583, enlA) were
detected in E. faecalis M2M6 and three (for ent1071A-
ent1071B, entV583, enlA) in E. faecalis M1S20. Among
the E. faecium isolates, the entA gene was detected in 13
(86.6 %) out of the 15 evaluated isolates and, associated
with the entB gene, in 7 (53.8 %) of the isolates (Table 5).
The ent96, entK4, entP and entXA-entXB and hirJM79
bacteriocin-producing genes were shown to have a lower
incidence (3.5 to 17.8 %) in the evaluated isolates while
the aviA, bac31, bacMC4, entAS48, entIT, entL50A-
entL50B, entQ and munL structural genes, could not be
detected in any of the evaluated isolates. E. faeciumM3K31 was shown to encode only the entP gene
(Table 5).Potential virulence factors, antibiotic susceptibility and
hemolytic activity
When the previously selected 9 bacteriocinogenic E.
faecalis isolates were evaluated for potential virulence
factors the presence of the cylLL-cylLS genes, encoding the
two peptide cytolysin (hemolysin-bacteriocin) precursor,
was detected in three isolates. However, only E. faecalis
PM2-13 showed the presence of the cylLMAB genes for
expression of cytolysin. Accordingly, only E. faecalis
PM2-13 showed β-hemolytic activity when streaked on
blood agar plates. Only two E. faecalis isolates encoded agg
but none encoded the esp gene. Most E. faecalis isolates
encoded ace, gelE and sprE but E. faecalis M1S9 and E.
faecalis M3S1 did not encode any of the three cited genes
(Table 6). All the evaluated E. faecalis strains hydrolysed

















911 935 936 939 4031 4032
E. faecalis
M2M6 0.50 0.06 0.05 0.12 0.06 0.06 0.05 0.06 0.06 0.06 0.06
M3M42 0.49 0.06 0.05 0.12 0.06 0.06 0.06 0.06 0.11 0.57 0.06
PM2-13 0.10 0.13 1.05 0.29 0.27 0.22 0.15 0.29 0.15 0.15 0.27
E. faecium
M1M10 9.1 2.6 16.3 2.2 4.3 34.5 8.5 18.6 3.9 3.5 16.3
M3M31 3.6 3.8 97.9 8.3 19.8 4.1 7.9 18.3 8.2 5.1 12.5
M3M32 3.8 1.9 288.4 35.0 20.1 7.7 7.8 34.9 14.6 4.2 34.7
M3K31 27.6 30.7 1.1 × 106 3.0 × 105 1.7 × 103 12.2 1.1 × 103 6.0 × 103 3.9 × 104 1.7x106 8.6 × 106
PM1-27 1.9 2.3 9.3 7.5 3.7 4.8 3.8 8.7 4.4 1.9 8.4
E. mundtii
M2M33 NA 0.24 0.23 0.17 0.19 0.17 8.74 0.07 0.08 0.08 0.16
L. brevis
PM1-26 3.8 1.9 29.1 4.4 4.7 5.0 3.8 9.4 4.4 1.8 8.6
aAntimicrobial activity measured by MPA and expressed as 103 × BU/mL. NA, No antimicrobial activity detected. Most of the data are means from two
independent determinations in triplicate
bSource of indicator microorganisms indicated in Table 1
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encoding gelE-sprE.
Antibiotic susceptibility of the 27 selected bacterioci-
nogenic enterococci revealed that all of them (100 %)
were resistant to at least one of the tested antibiotics.
Furthermore, 85 % of the isolates were resistant to
rifampicin, 77 % to tetracycline, 50 % to erythromycin,
44 % to cyprofloxacin, 29 % to chloramphenicol, 28 % to
nitrofurantoin, 29 % to gentamycin and ampicillin, 25 %
to penicillin, and 7 % to vancomycin. However, E.
faecalis M3M42 and E. faecium M3K31 were only
resistant to rifampicin while E. faecalis M2M6 was
sensitive to all antibiotics tested. All isolates were
sensitive to teicoplanin. The genotypic evaluation of the
antibiotic resistance profile of the enterococci evaluated
was not pursued in this study.
Safety assessment of E. faecium M3K31
The sensitivity of E. faecium M3K31 to ampicillin
resulted in a minimum inhibitory concentration (MIC) ≤
2 mg/L and, thus, susceptible to ampicillin according to
EFSA guidelines [19]. This isolate also showed the
absence of the virulence markers esp, hylEfm and IS16.
Molecular genotyping of selected enterococcal strains by
ERIC-PCR and MLST analysis
The ERIC-PCR fingerprints of the nine most antagonis-
tic E. faecalis strains isolated from griffon vultures feces
and those from other E. faecalis strains from different
food, environmental and clinical origin, revealed 2 differ-
ent clusters (50 % similarity). The first cluster includedall the isolates from griffon vulture feces and other E.
faecalis strains, mostly from human clinical origin. The
second cluster included only E. faecalis strains from
different origins (Fig. 1a). The ERIC-PCR dendrogram
showing the genetic relatedness between E. faecium
isolates from different origins could be also divided into
two clusters. One cluster contained 13 out of the 14
most antagonistic E. faecium isolates from griffon
vultures showing 60 % similarity. The second cluster
grouped all the E. faecium isolates from different origins
including E. faecium M4M2, isolated from griffon vul-
tures. Among the griffon vulture isolates only E. faecium
BS15 and E. faecium CS14 showed an almost identical
genotype (Fig. 1b).
Comparison of the resulting allelic profiles of E.
faecalis M3M42 and M1S19 in the E. faecalis MLST
database permitted their annotation as sequence types
ST167 and ST76, respectively. On the other hand, E.
faecium M1M10, E. faecium M3K31 and E. faecium
PM1-27 were annotated as sequence types ST22, ST76
and ST670, respectively, in the E. faecium MLST
database. Comparative eBURST analysis of the resulting
sequence types (STs) permitted their location into
clusters of related STs (Additional file 1: Figure S1).
Purification of bacteriocins, mass spectrometry analysis
and amino acid sequencing
Two of the bacteriocinogenic enterococci isolated from
griffon vulture feces, E. faecium M1M10 and E. faecium
M3K31 with high antimicrobial activity in their superna-
tants and encoding several or a single bacteriocin structural
Table 5 PCR amplification of bacteriocin structural genes from selected bacteriocinogenic lactic acid bacteria (LAB) isolates
Isolate aviA bac31 bacMC4 breB ent96 ent1071A-
ent1071B
entA entAS-48 entB entIT entJSA-entJSB entK4 entL50A-entL50B entP entQ entV583 entXA-entXB enlA hirJM79 munL pedA-1
E. faecalis
AS10 - - - - - - - - - - - - - - - + - - - - -
M1M32 - - - - - + - - - - - - - - - + - + - - -
M1S19 - - - - - + - - - - - - - - - + - + - - -
M1S20 - - - - - + - - - - - - - - - + - + - - -
M2M6 - - - - + + - - - - + - - - - + - + - - -
M2M39 - - - - + + - - - - - - - - - + - + - - -
M3M42 - - - - - - - - - - + - - - - + - - - - -
M3S1 - - - - - - - - - - - - - - - + - + - - -
PM1-27 - - - - - - - - - - - - - - - + - - - - -
PM2-13 - - - - - - - - - - - - - - - + - - - - -
E. faecium
AS41 - - - - - - + - + - - - - - - - + - - - -
BS15 - - - - - - + - + - - - - - - - - - - - -
CS14 - - - - - - + - + - - - - - - - - - - - -
CS46 - - - - - - + - + - - - - - - - + - - - -
M1M10 - - - - + - + - + - - + - - - - + - - - -
M1M26 - - - - - - + - - - - - - - - - - - + - -
M2S31 - - - - - - + - + - - - - - - - - - - - -
M2M31 - - - - - - + - + - - - - - - - + - - - -
M3M32 - - - - - - + - - - - - - - - - + - - - -
M3K31 - - - - - - - - - - - - - + - - - - - - -
M4M2 - - - - - - - - - - - - - - - - - - - - -
PM1-27 - - - - - - + - - - - - - - - - - - - - -
PM1-36 - - - - - - + - - - - - - - - - - - + - -
PM1-37 - - - - - - + - - - - - - - - - - - - - -
PM1-47 - - - - - - + - - - - - - - - - - - - - -
E. hirae
M4S3 - - - - - - - - - - - - - - - - - - - - -
E. mundtii
M2M33 - - - - - - - - + - - + - - - - - - - - -
L. brevis













Table 6 PCR amplification of genes related to potential virulence in E. faecalis
Isolate Virulence determinants
ace agg cylA cylB cylLL-cylLS cylM efaAfm efaAfs esp gelE sprE
E. faecalis
AS10 + - - - - - - + - + +
M1M32 + + - - - + - + - + +
M1S19 - + + + + - - + - - -
M1S20 + - - - - - - + - + +
M2M6 + - - - - - - + - + +
M2M39 + - - - - - - + - + +
M3M42 + - - - - + - + - + +
M3S1 - - + + + - - + - - -
PM2-13 + - + + + + - + - + +
A
B
Fig. 1 Dendrogram of ERIC-PCR showing the relatedness amongst the E. faecalis (a) and E. faecium (b) isolates from griffon vulture feces and
enterococcal isolates from other food, environmental and clinical origin. Source abbreviations as indicated in Table 1
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Arbulu et al. BMC Microbiology  (2016) 16:228 Page 10 of 15gene, respectively, were selected for purification of the bac-
teriocins being produced. Purification of the antimicrobial
activity of E. faecium M1M10, encoding five bacteriocin
structural genes, permitted a 1397-fold increase of its spe-
cific activity and a 32 % recovery of the initial antimicrobial
activity. MALDI-TOF MS of the purified peptide showed a
major peak of 5519.8 Da, suggesting the peptide was puri-
fied to homogeneity (Fig. 2a). Furthermore, determination
of the N-terminal amino acid sequence of the purified
peptide by Edman degradation permitted identification of
its 15 N-terminal amino acids as ENDHRMPNELNRPNN,
which unambigously correspond to the N-terminal
sequence of the enterocin B (EntB). However, EntB has a
calculated theoretical molecular mass of 5465.2 Da. Purifi-
cation of the antimicrobial activity of E. faecium M3K31,A
C
Fig. 2 MALDI-TOF MS analysis of purified bacteriocins from E. faecium M1M
of the purified bacteriocin from E. faecium M3K31 (c). The carboxy-terminal
LTTGGKAGW (top line) and the amino-terminal (b-series) shows the 14-resi
molecular mass in daltonsencoding the entP gene, permitted an 897-fold increase of
its specific activity and a 11 % recovery of the initial anti-
microbial activity. MALDI-TOF MS analysis of the purified
peptide showed a major peak of 4328.1 Da (Fig. 2b).
Furthermore, the de novo amino acid sequencing of the
resulting peptide by MALDI TOF/TOF tandem MS per-
mitted identification of the carboxy-terminal (y-ion series)
27-residue peptide SVDWGKAIGIIGNNAAANLTTGGK
AGW and the amino-terminal (b-ion series) 14-residue
peptide AAANLTTGGKAGWK (Fig. 2c), identical to the
C-terminal amino acid sequence of enterocin HF (EntHF)
(GenBank accession numbers P86183 and KJ442693), and
with a theoretical molecular mass of 4330.9 Da. Primers
devised from the nucleotide sequence of EntHF from
GenBank accession number KJ442693 and PCRB
10 (a) and E. faecium M3K31 (b). MALDI TOF/TOF tandem MS analysis
(y-ion series) shows the 27-residue peptide SVDWGKAIGIIGNNAAAN
due peptide AAANLTTGGKAGWK (bottom line). Numbers indicate
Arbulu et al. BMC Microbiology  (2016) 16:228 Page 11 of 15amplifications and sequencing of the resulting fragments,
confirmed that E. faeciumM3K31 encoded entHF.
Antimicrobial activity of purified enterocin A (EntA) and
enterocin HF (EntHF) against Listeria spp
The sensitivity of several Listeria spp. to purified EntA,
produced by E. faecium T136 and a potent antilisterial
class IIa bacteriocin and to EntHF, produced by E.
faecium M3K31, is shown in Table 7. Purified EntHF
showed a higher specific antimicrobial activity against
Listeria spp. than purified EntA. Furthermore, L.
ivanovii CECT913 was the most sensitive indicator
strain for both bacteriocins.
Discussion
Among other features, most bacteria produce compounds
that inhibit competing and pathogenic microorganisms,
improving host health [7, 25]. Since griffon vultures feed
regularly on carcasses from dead birds and mammals, it
may be hypothesized that vultures could benefit them-
selves hosting bacteriocin-producing LAB to combat bac-
terial pathogens. In this study, 36 % of the evaluated LAB
isolates showed direct antimicrobial activity. The entero-
cocci comprised the largest LAB group with antimicrobial
activity (91 %) with E. faecium (40 %) as the most identi-
fied antagonistic species. Enterococci with antimicrobial
activity have been previously identified from LAB isolated
from mammals, birds and fish [10–12], but not with this
elevated percentage of isolation. Enterococci are also the
most common species in cloacal and pharyngeal samples
of Euroasian griffon vultures [26] and in Turkey and Black
vultures whereas enterococcal symbionts living in the
hoopoe (Upua epops) uropygial gland produce bacterio-
cins active against Gram-positive pathogens [27]. Thus,
LAB with antimicrobial activity isolated from griffon vul-
ture feces mainly contains bacteriocinogenic enterococci.
In this work none of the LAB isolated from griffon
vultures showed antagonistic activity against any of the
four Gram-negative indicator bacteria evaluated, includ-
ing two C. jejuni strains. Since griffon vultures are not a
reservoir for Campylobacter spp. [26, 28], perhaps
bacteria different than LAB may inhibit or control their
presence in this reservoir. Several nonribosomal lipopep-
tides produced by Bacillus and Paenibacillus spp. haveTable 7 Antimicrobial activitya of chromatographically purified ente


















Enterocin HF 1,168 4 8.3 × 109 582 464
Enterocin A 8 9 19,000 10 5
Most of the data are means from two independent determinations in triplicate
aAntimicrobial activity measured by MPA and expressed as BU/ng of purified bacte
bSource of indicator microorganisms indicated in Table 1shown antagonistic activity against C. jejuni [29]. Thus,
these bacteria would be further evaluated for antimicro-
bial activity against C. jejuni when identified from
animal and food reservoirs [30]. When selected LAB
were evaluated for antimicrobial activity in their super-
natants, the E. faecalis isolates (Table 2) were less active
than E. faecium and other LAB isolates (Table 3), which
has been observed from enterococci from other sources
[10–12, 31]. But of interest is the high antimicrobial
activity of E. faecium M3K31 against most bacterial
indicators, including L. lactis BB24 (Table 3) and most
of the Listeria spp. evaluated (Table 4).
In this study, most selected bacteriocinogenic LAB
isolates encoded a variable number of bacteriocin
structural genes (Table 5). However, the presence of
structural bacteriocin-producing genes, either alone or
in combination with others, seems to be common in
bacteriocinogenic enterococci from human, animal,
clinical, food, agricultural and environmental sources
[10–12]. Furthermore, is also difficult to find a correl-
ation between the number of bacteriocin structural
genes and the antagonistic activity and antimicrobial
spectrum of the isolates. It may be hypothesized that
some bacteriocin-producing genes may be silent, that
modifications in the promoter region may affect
transcription, and that immunity/regulation/transport of
the synthesized bacteriocin may also be impaired. The
production of bacteriocins is also regulated by environ-
mental factors such as the temperature [32].
The enterococci are LAB with a beneficial role in the
sensory characteristics of fermented foods and have been
successfully used as starter and adjunct cultures, and
permitted as probiotics [33]. However, the enterococci
are also gastrointestinal (GI) tract colonizers responsible
of nosocomial and, to a lesser extent, community ac-
quired infections [34]. E. faecalis harbours significantly
more virulence determinants than E. faecium [10, 18]
and, therefore, we screened the bacteriocinogenic E.
faecalis isolates for presence of virulence determinants
(Table 6). In this study, only E. faecalis PM2-13 ampli-
fied all genes for expression of cytolysin. Insertion/dele-
tion events leading to truncated or absent cyl genes and
possible sequence divergences may explain the difficul-
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riocin
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and sprE. Protease expression seems to be strain specific
and not representative of clinical isolates although regu-
latory genes must be also active, to permit protease ex-
pression [35]. None of the E. faecalis evaluated encoded
esp and this is considered a positive attribute since Esp
is supposed to promote primary attachment to surfaces
and escape from the immune system.
Enterococci are commonly resistant to macrolides,
cephalosporins and tetracycline and often exhibit
high-level resistance to gentamicin [36]. Vultures rely
greatly on food which usually derives from medicated
livestock that could lead vultures to the acquisition of
antimicrobial-resistant bacteria, modification of the nor-
mal microbiota and acquisition of pathogenic bacteria.
But, in this study several E. faecalis and E. faecium iso-
lates did not show a large antimicrobial resistance.
Moreover, E. faecium M3K31 was susceptible to ampicil-
lin and did not encode the virulence markers esp, hylEfm
and IS16 being considered, according to EFSA guidelines
[19], a safe probiotic for use in animal nutrition.
The virulence of the enterococci also reflects a selec-
tion for specific variants or clones with enhanced patho-
genic potential [37]. The epidemiological typing of E.
faecalis and E. faecium has mainly been performed by
ERIC-PCR and MLST analysis. As expected, E. faecalis
strains from griffon vulture feces showed a distinct
genetic relatedness among them and from other strains
from food, clinical and environmental origin when eval-
uated by ERIC-PCR (Fig. 1a). However, the E. faecium
strains formed a more conserved, but also distinct group
as compared to enterococcal isolates from different
origins (Fig. 1b). These results suggest the reliability of
ERIC-PCR for genotyping enterococci and, very likely,
for their specific monitoring.
Previous MLST studies have demonstrated the associ-
ation between specific clonal complexes and human
nosocomial infections for E. faecalis [38, 39] and E.
faecium [34]. Indeed, the majority of hospital-derived
isolates of E. faecalis cluster in two clonal complexes,
CC2 and CC9. However, in E. faecium the sequence
types ST17, ST18, ST78 and ST192 which were
previously designated clonal complex CC17, constitutes
a hospital-associated clade genetically distinct from most
commensal isolates [34, 37]. In this study, E. faecalis
M3M42 and E. faecalis M1S19 were identified with the
sequence types ST167 and ST76, respectively, none of
them included into the clonal complexes CC2 and CC9
represented by sequence types ST6 and ST9, respectively
(Additional file 1: Figure S1). In this context, E. faecalis
M3M42 sensitive to most antibiotics, free of most
virulence determinants and encoding gelE-sprE could be
considered a potential strain for production of bioactive
peptides with antihypertensive and antioxidant activity,during its growth on bovine skim milk [40, 41]. The
MLST analysis of the E. faecium isolates showed that
while E. faecium M1M10 (ST22) and E. faecium PM1-27
(ST670) remain close to strains from a hospital-
associated clade the strain of E. faecium M3K31 (ST176)
remains distant from those of the clonal complex CC17
and, thus, is considered a safe isolate (Additional file 1:
Figure S1).
For bacteriocinogenic isolates the possibility exists for
their antimicrobial activity being mediated by still un-
known or not yet described bacteriocins or by regulation
of the production of multiple encoded bacteriocins. In
this study, MALDI-TOF MS analysis and N-terminal
amino acid sequencing of the purified supernatant of E.
faecium M1M10, encoding several bacteriocin structural
genes, permitted the identification of a major peptide
fragment (Fig. 2a) unambigously recognized as the
N-terminal sequence of EntB [42]. The difference
between the obtained and the calculated molecular mass
of te EntB may be adscribed to still unknown modifica-
tions. Furthermore, the absence of other major peptide
fragments in the purified activity of E. faecium M1M10,
may imply that: (i) other encoded bacteriocins are pro-
duced in much lower concentrations, (ii) their structural
genes remain silent and/or (iii) their production is regu-
lated by still unknown mechanisms.
On the other hand, MALDI-TOF MS analysis and the
de novo amino acid sequencing by MALDI TOF/TOF
tandem MS of the major peptide from the purified
supernatant of E. faecium M3K31 (Fig. 2b), encoding
entP and with antimicrobial activity against L. lactis
BB24, a LAB species with low or non-inhibitory activity
by class IIa bacteriocins [9], permitted the identification
of a peptide identical to the C-terminal amino acid
sequence of the bacteriocin EntHF. The difference be-
tween the measured and the calculated molecular mass
of EntHF, suggests the existence of a disulfide bond link-
ing the two known cysteine residues in the molecule. In
this context, mature EntHF is 91 % identical to mundti-
cin KS/enterocin CRL35 [43, 44] and 90 % identical to
mundticin L [45] and avicin A [46]. These bacteriocins
display a high antilisterial activity, and enterocin CRL35
has even been postulated as a promising alternative
agent for the in vivo prevention of Listeria spp. infec-
tions [47]. The absence of the bacteriocin EntP in the
purified peptide fraction from E. faecium M3K31, imply
that further studies on the regulation of the expression
of bacteriocin structural genes in bacteriocinogenic
enterococci would be pursued.
The specific antimicrobial activity of purified EntA
and EntHF against Listeria spp. was higher for EntHF as
compared to EntA (Table 7). Thus, although EntA is one
of the most potent class IIa bacteriocins [48], EntHF is
even more potent than EntA against Listeria spp. The
Arbulu et al. BMC Microbiology  (2016) 16:228 Page 13 of 15determination of the three-dimensional (3D) structure of
EntHF, produced by E. faecium M3K31, suggest that
apparently the β-sheet-like N-terminal domain mediates
initial binding to the target cell whereas the helix-
containing C-terminal half penetrates into the hydropho-
bic core of target-cell membranes, docks to domains of
specific protein receptors and causes dead of sensitive
cells [49]. Modifications in the amino acid composition of
the C-terminal end of class IIa bacteriocins may alter the
manner and/or extent to which bacteriocins interact with
putative or cognate receptors and even with cognate im-
munity proteins in the membrane of target cells [50, 51].
This would explain why the antimicrobial spectra of simi-
lar class IIa bacteriocins and the susceptibility of sensitive
cells to a given bacteriocin, varies much more than would
be expected from their known amino acid sequences.
Accordingly, EntHF may be considered a bacteriocin of el-
evated potential biotechnological interest as a natural food
preservative and a therapeutic antimicrobial agent for
human and veterinary applications. Furthermore, because
EntHF is a primary metabolite of a linear peptidic nature,
it may be considered suitable for the development of novel
bacteriocin quimeras with increased target specifity and
antimicrobial activity by peptide bioengineering.
Within LAB, enterococci are increasingly used as
probiotics. Most probiotics enhance intestinal barrier
function, display immunomodulatory activity and exert
protective effects due to production of antimicrobial com-
pounds including bacteriocins [4, 52]. Moreover, the eluci-
dation of the draft genome of E. faecium M3K31 has
confirmed the existence in this strain of the EntHF bio-
synthetic cluster, the enterocin P structural and immunity
genes, and a gene encoding the putative antimicrobial
peptide SRCAM 602 [53]. Accordingly, E. faecium M3K31
producing EntHF and free of defined virulence markers,
would be also considered a safe probiotic for further
biotechnological applications including animal nutrition.
Conclusions
This study has determined that enterococci is the largest
LAB group with bacteriocinogenic activity, isolated from
griffon vulture feces. However, the absence of LAB with
antagonistic activity against Gram-negative bacteria
suggest that bacteria, other than LAB, would be investi-
gated for their activity against this bacterial group. Most
enterococci encoded multiple bacteriocins although is
production seems to be regulated by still unknown and
deficiently evaluated mechanisms. Moreover, E. faecium
M3K31 has been identified as producer of EntHF, a
bacteriocin with remarkable antimicrobial activity
against most evaluated Listeria spp. and elevated interest
as a natural food preservative. E. faecium M3K31, absent
of defined virulent markers, would be also considered a
safe probiotic for use in animal nutrition.Additional file
Additional file 1: Figure S1. Comparative eBURST analysis against whole
MLST from E. faecalis (A) and E. faecium (B). The indicated ST sequences
belong to hospital-adapted clonal complexes (CC). In Figure 1A, ST6 belongs
to clonal complex 2 (CC2) and ST9 to CC9. In Figure 1B, the ST17, ST18 and
ST78 belong to CC17, CC18 and CC78, respectively. Table S1. Primers and
PCR conditions for bacteriocin amplification used in this study. References
for Table S1. (DOC 655 kb)
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